(n, androstmediom ( A4) were higher in males, while those of pre nenolone (Preg), 170Hqegnenolone (170H-pre& 170H-progesterone flOHP), DHA, A5-an&ostmediol and 1 B -estradiol were slightly but significantly higher in females. T h e was no sex difference in AF levels of preg. sulfate (PSI or DHA sulfate, progesterone, estrone, cortisol and cortisone. Among 4 pregnancies a t risk for congenital adrenal hyperplasia (CAH) due t o 21-hydroxylase defect, antenatal diagnosis (Dgs) of CAH was made in 1, on the high AF levels of OHP and confirmed a t birth. We then investigated whether estlmating AF levels of other steroids could consolidate the Dgs.
In the AF of the affected girl, T, dk were also drastically elevated, PS, r e g and 170Hpreg were just above normal limits (NL), while the other a m o n e s were normal. Similarly T, A4 and OHP were drastically elevated in the peripheral blood a t birth. In contrast none of the estimations in the cord blood would have made the dgs with certainty, although OHP was above normal.
In The patient is the second child of healthy unrelated parents,his older brother is normal. At birth the genitalia were ambiguous; the phallus was adequate in size but therr was chordee and perineal hypospadias. The labio-scrota1 folds were fused. Gonads were palpable in both groins. The karyotype (blood and skin) was nor= ma1 female XX. Biopsy of both gonads showed immature testes with no ovarian elements; the XX genotype was confirmed in gonadal ti? sue. Laparotomy showed normal male and absent female internal ge nitalia. Hypospadias repair was undertaken and the child was re% red in the male sex. At 6 years he was noted to be virilising.He had shown rapid growth and weight gain and development of pubic and axillary hair. Plasma steroid: by RIA and urinary steroidsby GLC/MS indicated partial 21-hydroxylase deficiency. There was normal suppression with exogenous steroids and a selenocholesterol scan showed bilateral adrenal hyperplasia.He is maintainedon hydro-cortisone and continues to make a good progress at the age of 9.This patient has an apparently unique combination of genetic endocrine defects unlikely to be due to chance. Subjects affected by pituitary dwarfism and treated with Growth Hormone (GH) preparations extracted according to the Raben proce= dure have a high incidence of anti-GH antibodies. These antibodies were detected in 7 out of 22 patients treated with the GRORM (Se= rono) clinical preparation. Two of them showed a significantly im= paired growth rate (19 and 28% less than the mean value in the other 20 patients). Their sera bound labelled GH with a high affiz nity (Kaf 0.68 and 1.16 x ~o -~M ) .
The binding capacity was 0.32 and 0.75 mgGH/l, respectively. We fractionated the GRORM preparation by gel filtration (Sephadex G-100) and tested the two sera with different protein peaks. The fraction having a m.w.of 80,000, a Kav of 0.20 and an immunoreactivity equal to 84% of the GH mono= mer was bound more and with a higher association rate. This frac= tion is 12-24% of the GRORM preparation and it probably consists of GH aggregates. The present data suggests a major role of the GH aggregates i n eliciting anti-GH antibodies production in these patients.
